Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ocuspecto Oy
OY
Active
Y-tunnus 2478157-7
Kaarinantie 700, 20540
Turku
Research and development on medical sciences
· NACE 72191
Est. 2012
— employees
Watchlist
Share
Finland
/
Companies
/
Research and development on medical sciences
/
Ocuspecto Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
EBITDA
EUR millions
0M
0M
1M
1M
1M
-1M
2018
-1M
2019
0M
2020
Income statement
EUR thousands
Item
2018
2019
2020
Revenue
169
171
214
Staff expenses
−945
−736
−365
EBITDA
−970
−660
−315
Depreciation & amort.
−187
−201
−202
EBIT
−1 157
−861
−517
Net financials
−46
−34
−40
Profit before tax
−1 203
−895
−557
Tax
−0
−0
−0
Net profit
−1 203
−895
−557
Balance sheet
EUR thousands
Item
2018
2019
2020
Total assets
2 292
2 131
2 096
Equity
100
−86
−372
Long-term debt
1 610
1 771
1 987
Short-term debt
582
446
482
Total debt
2 192
2 217
2 468
Financial ratios
5-year trend
EBITDA margin
-147.2%
This company
15.8%
Market median
-1032% vs market
2018
2020
Equity ratio
-17.7%
This company
38.2%
Market median
-146% vs market
2018
2020
Return on equity
-55742800.0%
This company
18.4%
Market median
-302950100% vs market
2018
2020
Net profit margin
-260.8%
This company
8.1%
Market median
-3320% vs market
2018
2020
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
2018
2020
Debt / equity
6.64×
This company
0.62×
Market median
-971% vs market
2018
2020
Annual reports & filings
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
View
PDF
More on Ocuspecto Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
